Below is a list of the 2013 BIO Investor Forum speakers. To view or download the full program schedule, please click here.
For questions about programming, please contact Sondra Behan, Manager, Industry research and Programs, Business Development, Biotechnology Industry Organization at: sbehan@bio.org.
| Photo | Name and Title | Panel, Date, Time | Location |
 |
Srini Akkaraju, MD, PhD General Partner Sofinnova Ventures |
Early Stage Venture Financing – Will Current Trends Continue into 2014? Wednesday, October 9, 2013 3:30 p.m. - 4:25 p.m. |
Sunset Court |
 |
Marianne Andreach VP of Strategic Marketing & Product Planning Esperion Therapeutics |
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care Wednesday, October 9, 2013 9:00 a.m. - 9:55 a.m. |
Twin Peaks North/South |
 |
Brian Atwood Managing Director Versant Ventures |
Early Stage Venture Financing – Will Current Trends Continue into 2014? Wednesday, October 9, 2013 3:30 p.m. - 4:25 p.m. |
Sunset Court |
 |
Jeffrey A. Baumel Partner Dentons |
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective Wednesday, October 9th 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
Alexis Borisy Partner Third Rock Ventures |
Early Stage Venture Financing – Will Current Trends Continue into 2014? Wednesday, October 9, 2013 3:30 p.m. - 4:25 p.m. |
Sunset Court |
 |
James B. Breitmeyer, MD, PhD Executive Vice President, Division President Cancer Vaccines Bavarian Nordic A/S |
The Ultimate Rejection: Fighting Cancer with Immunotherapy Tuesday, October 8, 2013 10:30 a.m. - 11:25 a.m. |
Twin Peaks North/South |
 |
Mark Charest Vice President New Leaf Venture Partners |
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective Tuesday, October 8, 2013 12:00 p.m. - 1:25 p.m. |
Sunset Court |
 |
Margarita Chavez Director AbbVie Biotech Ventures |
Early Stage Venture Financing – Will Current Trends Continue into 2014? Wednesday, October 9, 2013 3:30 p.m. - 4:25 p.m. |
Sunset Court |
 |
Steve Conafay, JD Principal The Conafay Group |
GAINing Ground in Antibiotics– New Incentives for Biopharma Tuesday, October 8, 2013 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
|
|
Ashley Dombkowski, PhD Managing Director Bay City Capital |
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective Tuesday, October 8, 2013 12:00 p.m. - 1:25 p.m. |
Sunset Court |
 |
Michael Dybbs, PhD Principal New Leaf Venture Partners |
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective Wednesday, October 9th 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
David Donabedian Vice President, Venture Investments AbbVie Biotech Ventures |
Early Stage Venture Financing – Will Current Trends Continue into 2014? Wednesday, October 9, 2013 3:30 p.m. - 4:25 p.m. |
Sunset Court |
|
|
Charles C. Duncan, PhD Managing Director & Senior Research Analyst Piper Jaffray |
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care Wednesday, October 9, 2013 9:00 a.m. - 9:55 a.m. |
Twin Peaks North/South |
 |
Michael J. Eichberg, PhD Senior Director, Alliance Management Achaogen |
GAINing Ground in Antibiotics– New Incentives for Biopharma Tuesday, October 8, 2013 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
Dr. E. Cartier Esham Acting Executive Vice President Emerging Companies, Health and Regulatory Affairs Biotechnology Industry Organization |
GAINing Ground in Antibiotics– New Incentives for Biopharma Tuesday, October 8, 2013 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
|
|
Laurent Fischer, MD Chairman and CEO Jennerex Biotherapeutics |
The Ultimate Rejection: Fighting Cancer with Immunotherapy Tuesday, October 8, 2013 10:30 a.m. - 11:25 a.m. |
Twin Peaks North/South |
 |
Simone Fishburn, PhD Senior Editor BioCentury Publications |
Fireside Chat October 9, 2013 10:30 a.m. - 11:30 a.m. |
Twin Peaks North/South |
 |
Lawrence Fong, MD Associate Professor, Department of Medicine (Hematology/Oncology) UCSF Medical Center |
The Ultimate Rejection: Fighting Cancer with Immunotherapy Tuesday, October 8, 2013 10:30 a.m. - 11:25 a.m. |
Twin Peaks North/South |
|
|
Nicholas Franano, MD Founder, President & CEO Novita Therapeutics |
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"? Tuesday, October 8, 2013 3:30 p.m. - 4:25 p.m. |
Twin Peaks North/South |
 |
Paul J. Hastings President and CEO OncoMed Pharmaceuticals |
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective Wednesday, October 9th 2:00 p.m. - 2:55 p.m. Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary Wednesday, October 9, 2013 12:30 p.m. - 1:25 p.m |
Twin Peaks North/South |
 |
James I. Healy, MD, PhD General Partner Sofinnova Ventures |
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary Wednesday, October 9, 2013 12:30 p.m. - 1:25 p.m |
Sunset Court |
 |
Sharon Hesterlee, PhD Vice President Research Parent Project Muscular Dystrophy |
A Guide to Effective Patient Foundation and Life Science Industry Collaborations Tuesday, October 8, 2013 9:00 a.m. - 9:55 a.m. |
Twin Peaks North/South |
 |
Paul G. Higham CEO immatics biotechnologies GmbH |
The Ultimate Rejection: Fighting Cancer with Immunotherapy Tuesday, October 8, 2013 10:30 a.m. - 11:25 a.m. |
Twin Peaks North/South |
|
|
Thomas E. Hughes, PhD President & CEO Zafgen |
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary Wednesday, October 9, 2013 12:30 p.m. - 1:25 p.m |
Sunset Court |
 |
Thomas Kapsner CEO Morphochem AG |
GAINing Ground in Antibiotics– New Incentives for Biopharma Tuesday, October 8, 2013 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
J. Joseph Kim President, Chief Executive Officer, Director Inovio Pharmaceuticals |
The Ultimate Rejection: Fighting Cancer with Immunotherapy Tuesday, October 8, 2013 10:30 a.m. - 11:25 a.m. |
Twin Peaks North/South |
 |
Michael Kelly, PhD Chief Scientific Officer CureDuchenne |
A Guide to Effective Patient Foundation and Life Science Industry Collaborations Tuesday, October 8, 2013 9:00 a.m. - 9:55 a.m. |
Twin Peaks North/South |
 |
Jan M. Lundberg, Ph.D Eli Lilly Executive Vice President, Science and Technology President Lilly Research Laboratories |
Fireside Chat October 9, 2013 10:30 a.m. - 11:30 a.m. |
Twin Peaks North/South |
 |
Gail Maderis President & CEO BayBio |
A Guide to Effective Patient Foundation and Life Science Industry Collaborations Tuesday, October 8, 2013 9:00 a.m. - 9:55 a.m. |
Twin Peaks North/South |
|
|
Michael Margolis, RPh Managing Director ROTH Capital Partners |
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective Wednesday, October 9th 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
Ed Mathers Partner New Enterprise Associates |
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care Wednesday, October 9, 2013 9:00 a.m. - 9:55 a.m. Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary Wednesday, October 9, 2013 12:30 p.m. - 1:25 p.m |
Twin Peaks North/South |
|
|
Erin McCallister Senior Editor BioCentury Publications |
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary Wednesday, October 9, 2013 12:30 p.m. - 1:25 p.m |
Sunset Court |
 |
Evan McCulloch, CFA Portfolio Manager Franklin Templeton Investments |
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective Tuesday, October 8, 2013 12:00 p.m. - 1:25 p.m. |
Sunset Court |
 |
Steven J Mento, PhD President and CEO Conatus Pharmaceuticals |
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective Wednesday, October 9th 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
Andrew Merickel, PhD Partner Knobbe Martens |
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"? Tuesday, October 8, 2013 3:30 p.m. - 4:25 p.m. |
Twin Peaks North/South |
|
|
Deepa Pakianathan, PhD General Partner Delphi Ventures |
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"? Tuesday, October 8, 2013 3:30 p.m. - 4:25 p.m. |
Twin Peaks North/South |
|
|
Joseph Pantginis, PhD Senior Research Analyst ROTH Capital Partners |
The Ultimate Rejection: Fighting Cancer with Immunotherapy Tuesday, October 8, 2013 10:30 a.m. - 11:25 a.m. |
Twin Peaks North/South |
 |
Hemai Parthasarathy, Ph.D. Scientific Director Breakout Labs/Thiel Foundation |
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"? Tuesday, October 8, 2013 3:30 p.m. - 4:25 p.m. |
Twin Peaks North/South |
 |
Eugene Rozelman Managing Director Biopharma Investment Banking, Canaccord Genuity |
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective Tuesday, October 8, 2013 12:00 p.m. - 1:25 p.m. |
Sunset Court |
|
|
Susan Schaeffer Editor BioCentury Publications |
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary Wednesday, October 9, 2013 12:30 p.m. - 1:25 p.m |
Sunset Court |
 |
Andrew J. Schwab Managing Partner AM Ventures |
Early Stage Venture Financing – Will Current Trends Continue into 2014? Wednesday, October 9, 2013 3:30 p.m. - 4:25 p.m. |
Sunset Court |
|
|
Brad Spellberg, MD Investigator LA BioMed |
GAINing Ground in Antibiotics– New Incentives for Biopharma Tuesday, October 8, 2013 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
Gregory C. Simon CEO Poliwogg |
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"? Tuesday, October 8, 2013 3:30 p.m. - 4:25 p.m. |
Twin Peaks North/South |
|
|
Eugene Sun, MD Executive Vice President, Research & Development Rib-X Pharmaceuticals |
GAINing Ground in Antibiotics– New Incentives for Biopharma Tuesday, October 8, 2013 2:00 p.m. - 2:55 p.m. |
Twin Peaks North/South |
 |
David Thomas, CFA Director, Industry Research & Analysis BIO |
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective Tuesday, October 8, 2013 12:00 p.m. - 1:25 p.m. |
Sunset Court |
|
|
Luke Timmerman Vice President, Life Sciences Initiatives Xconomy |
Early Stage Venture Financing – Will Current Trends Continue into 2014? Wednesday, October 9, 2013 3:30 p.m. - 4:25 p.m. |
Sunset Court |
 |
Effie Toshav Partner Fenwick & West LLP |
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective Tuesday, October 8, 2013 12:00 p.m. - 1:25 p.m. |
Sunset Court |
 |
Michael Wyzga President & CEO Radius Health |
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care Wednesday, October 9, 2013 9:00 a.m. - 9:55 a.m. |
Twin Peaks North/South |